Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper.
Herpain A, Bouchez S, Girardis M, Guarracino F, Knotzer J, Levy B, Liebregts T, Pollesello P, Ricksten SE, Riha H, Rudiger A, Sangalli F. Herpain A, et al. Among authors: pollesello p. J Cardiovasc Pharmacol. 2019 Jan;73(1):3-14. doi: 10.1097/FJC.0000000000000636. J Cardiovasc Pharmacol. 2019. PMID: 30489437 Free PMC article. Review.
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
Papp Z, Édes I, Fruhwald S, De Hert SG, Salmenperä M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikström BG, Jörgensen K, Filippatos G, Parissis JT, González MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Papp Z, et al. Among authors: pollesello p. Int J Cardiol. 2012 Aug 23;159(2):82-7. doi: 10.1016/j.ijcard.2011.07.022. Epub 2011 Jul 23. Int J Cardiol. 2012. PMID: 21784540 Review.
The clinical effects of levosimendan are not attenuated by sulfonylureas.
Kivikko M, Nieminen MS, Pollesello P, Pohjanjousi P, Colucci WS, Teerlink JR, Mebazaa A. Kivikko M, et al. Among authors: pollesello p. Scand Cardiovasc J. 2012 Dec;46(6):330-8. doi: 10.3109/14017431.2012.725206. Epub 2012 Sep 25. Scand Cardiovasc J. 2012. PMID: 22928945
Renal effects of levosimendan: a consensus report.
Yilmaz MB, Grossini E, Silva Cardoso JC, Édes I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, Morelli A, le Noble J, Oldner A, Oulego Erroz I, Parissis JT, Parkhomenko A, Poelzl G, Rehberg S, Ricksten SE, Rodríguez Fernández LM, Salmenperä M, Singer M, Treskatsch S, Vrtovec B, Wikström G. Yilmaz MB, et al. Among authors: pollesello p. Cardiovasc Drugs Ther. 2013 Dec;27(6):581-90. doi: 10.1007/s10557-013-6485-6. Cardiovasc Drugs Ther. 2013. PMID: 23929366 Free PMC article. Review.
137 results